FeesSafety
Pluang+

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Company Fundamentals
03 Nov 2026, 19:00 WIB
Na
View Source
Bullish
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trials. Her leadership focuses on disciplined clinical execution, advancing blarcamesine development, and strengthening FDA collaboration to bring new treatments for CNS diseases. This marks a strategic step for Anavex's growth and regulatory progress.

Anavex Life Sciences' leadership change is the subject, here is Pluang's Health sector market snapshot. Of 150 priced Health-sector US stocks tradable on Pluang, 74 rose and 69 fell today. Notable movers include AHCO at USD 6.20 with a +4.91% change and 90% buy activity, NUVB at USD 4.81 with a +4.79% change, and ACB at USD 4.40 with a +4.27% change. Data as of Nov 03, 2026 19:02 WIB.

More News

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
24 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
24 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
Potato chips market to hit $84B by 2032, driven by flavor innovation and local manufacturing.

Potato chips market to hit $84B by 2032, driven by flavor innovation and local manufacturing.

The global potato chips market is expected to grow from $59.67 billion in 2026 to $84.26 billion by 2032, at a CAGR of 5.88%. Growth is fueled by local manufacturing, individual packaging, and flavor innovation, which help brands meet diverse consume...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App